StonvexLoading…
StonvexStonvexStonvexCore line items from EXLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.09B | $1.84B | $1.63B | $1.41B |
Operating Income | $313.75M | $263.62M | $238.75M | $192.16M |
Net Income | $251.02M | $198.30M | $184.56M | $142.97M |
EPS (Diluted) | $1.54 | $1.21 | $1.10 | $0.85 |
Total Assets | $1.70B | $1.62B | $1.44B | $1.35B |
Total Liabilities | $789.53M | $688.54M | $552.53M | $587.94M |
Cash & Equivalents | $146.33M | $153.35M | $136.95M | $118.67M |
Free Cash Flow OCF − CapEx | $298.12M | $222.26M | $158.40M | $121.31M |
Shares Outstanding | 156.43M | 161.80M | 165.28M | 166.17M |